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Disruption of ephrin-A5 in developing Xenopus laevis embryos by shRNA
By: Sarah Engmark

Abstract (174)
Eph receptors are the largest class of receptor tyrosine kinases (RTKs) that participate in
bidirectional cell signaling with their cell surface ephrin ligands during the development of
vertebrate embryos. Ephrin-AS is one ligand that interacts with the EphA4 receptor, but is
present much earlier than EphA4 in developing Xenopus laevis embryos. This raises the
question why ephrin-AS is expressed so early and suggests that it may have a role in
embryonic development and tissue differentiation independent ofEphA4. This project
attempted to study ephrin-AS's function using a short hairpin RNA (shRNA) knockdown
approach. A vector encoding shRNA of the ephrin-AS mRNA under the control of a strong
eukaryotic promoter was injected into early Xenopus laevis embryos in the attempt to knock
down ephrin-AS expression and determine its function. A protein gel visualized the presence
of viable proteins and Western Blots visualized the knockdown attempts. The shRNA vector
used (pCAX+571) was determined not to have knocked down the expression of ephrin-AS;
thus ephrin-AS's function in embryonic development has yet to be determined.
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Introduction
Cells rely on signaling pathways for many different functions during all stages of life.
One of the most significant is the Eph-ephrin signaling pathway. The cell-bound ephrin
ligands activate the largest family of receptor tyrosine kinases (RTKs), the Eph receptors
(Sikkema eta!., 2012; Matsuo and Otaki, 2012). Both Ephs and ephrins are divided into an A
and B subclasses. Eph-A receptors generally interact with ephrin-A ligands and Eph-B
receptors generally interact with ephrin-B ligands. However, there are exceptions to this
interaction pattern, such as Eph-A4, which can bind to ephrin-B2, ephrin-B3, and ephrin-As;
and ephrin-A5, which binds toEph-A's and Eph-B2 (Matsuo and Otaki, 2012; Pasquale,
2004).

Eprhins are cell-anchored signals that transduce and receive signals to and from
corresponding Eph receptors through cell-cell contact, called bidirectional signaling (Cowan
and Henkemeyer, 2002; Pasquale, 2004; Winning and Krull, 2011). A-subclass ephrin
ligands attach to the outer leaflet of the plasma membrane by glycosylphosphatidylinositol
(GPI) linkage and transduce a signal by binding Eph-A receptors (Cowan and Henkemeyer,
2002; Fu eta!., 2012). B-subclass ephrin ligands have both transmembrane and cytoplasmic
domains (Fu eta!., 2012). They use conserved tyrosines in their cytoplasmic tails, which are
phosphorylated upon contact with Eph-B receptors to transduce a signal to their
corresponding Eph receptors. However, Eph receptors transduce signals by activating their
intracellular catalytic tyrosine kinase domain, causing a RTK cascade (Cowan and
Henkemeyer, 2002). The signal transduced after cell-cell contact between Eph and ephrin
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expressing cells has been shown to cause repulsion between the cells (Winning and Krull,
2011).

The Eph-ephrin bidirectional signaling and repulsion characteristics have been shown
to dramatically impact various diseases and developmental processes. Both forward and
reverse signaling have been linked to various malignant cancers (Sikkema et al. 2012). The
presence ofEph receptors and ephrins have been found to be upregulated in cancer cells and
their signaling has been shown to enhance cell migration and proliferation throughout the
body, which enhances cancer-promoting processes (Pasquale, 2008; Sikkema et al., 2012).
Intriguingly, Eph-ephrin signaling has also been linked to tumor-suppressing effects
(Pasquale, 2008; Sikkema et al., 2012). In the various cancers, Ephs and ephrins have been
found to play different roles. In breast cancer, for example, Eph-A2 and Eph-B4 are the most
studied receptors. Though there is still much that is not understood, it has been shown that
both receptors are extensively expressed; however, they do not seem to need ephrin
interaction to induce activation. In fact, the overexpression ofEph-A2 has been shown to
induce oncogenic transformation in human breast cancer (Pasquale, 2008).

Interestingly, Eph-ephrin signaling has a significant role in embryonic development.
Previous studies have found that Eph signaling is essential in neural development, mediating
cytoskeleton dynamics, guided migrations, and angiogenesis. Ephrin signaling has also been
linked to neural development, in addition to axon guidance (Sikkema et al., 2012). Ephephrin signaling has also been shown to induce cell migration, boundary formation, cell
position and shape by way of repulsion (Fu et al., 2012). Furthermore, Eph-ephrin signaling
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is essential in human placentation and has been shown to aid in attachment between
blastocysts and the endometrium in swine (Fu et al., 20 12).

One important formation during embryonic development is the formation of somites.
Somites are derived from one of the three germ layers, the mesoderm, which will eventually
go on to form vertebrae, ribs, muscle, connective tissues, and the sclerotome. During this
formation, interaction between Eph-A4 and ephrins is essential in the somites' boundary
formation. Furthermore, it has been shown, through a knockdown, that in chickens only EphA4 is necessary for somatic boundary formation (Matsuo and Otaki, 2012). Although, in this
case, only Eph-A4 was necessary to allow somite formation, Eph-ephrin signaling plays an
important role in boundary formations (Fu et al., 20 12).

Even though new information about Eph-ephrin signaling is continually being
elucidated, within the ephrin ligands ephrin-A5 remains a mystery, with some exceptions.
One exception is that it has been shown to be essential in retinocollicular mapping (Feldheim
et al., 2000). However, the specific functions ephrin-A5 plays in embryonic development
have yet to be determined. From a previous study we know that Eph-A4, a receptor that
interacts with ephrin-A5, is first present in Xenopus laevis at the gastrula stage (stages 10-12)
(Winning and Sargent, 1994). However, previous unpublished research from the Winning lab
found that ephrin-A5 is present at the zygote stage (stage 1; Ali and Winning, unpublished
results). This finding raises the question, why is the signal present before the receptor? The
fact that ephrin-A5 is present at such an early stage suggests that ephrin-A5 plays a
significant role in embryonic development. The purpose of this study is to test this hypothesis
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using shRNA to knockdown the expression of ephrin-A5 in Xenopus laevis, thus allowing the
determination of ephrin-A5 's function.

Materials and Methods

Bacterial Traniformation
Escherichia coli DH5a transformation with the pCAX plasmids encoding ephrin-A5
shRNA beginning at the 571 position (pCAX + 571) and 571 M shRNA (the mutated version
of 571 shRNA, pCAX + 571M) was accomplished by means of One Shot Chemically
Competent DH5a (Invitrogen), according to the manufacturer's instructions. The DH5u
solution was incubated on ice for 30 minutes, then heat-shocked at 42° C for 30 seconds. One
milliliter of S.O.C. medium was added and the culture was incubated at 37° C for one hour.
One hundred microliters was spread on aLB plate with Ampicillin (50!lg/mL) and incubated
at 37° C overnight.

Plasmid DNA Isolation
DHSu with the pCAX plasmids were inoculated into 10 mL of super broth containing
100 11g/ml ampicillin and incubated at 37°C overnight prior to plasmid purification using the
Wizard Plus Midi preps DNA Purification System. Ten milliliters of the bacterial culture was
pelleted in a fixed rotor centrifuge for 10 minutes at 10,000 x g at 4° C. Pellets were
suspended in 6.0 mL of Cell Resuspension Solution and 6.0 mL of Cell Lysis Solution was
added. The tubes were mixed by inversion and incubated at room temperature for 5 minutes.
Six milliliters of Neutralization Solution was added and the tubes were inverted. The tubes
were centrifuged in a fixed rotor for 15 minutes at 14,000 x gat 4° C. Ten milliliters of resin
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was added to the DNA supernatant and placed in the Midi column/syringe assembly.
Columns were placed on a vacuum until all liquid passed through, then 15 mL of Column
Wash Solution was added and left on the vacuum until all liquid had passed. The wash was
repeated and left on the vacuum to dry for 30 seconds. The columns were centrifuged for 2
minutes at 10,000 x g. The plasmid DNA was eluted from the column with 300 [!L of
nuclease free water. The water was left to sit for 1 minute and then the columns were
centrifuged in a fixed rotor for 5 minutes at 10,000 x g. The eluate was transferred to new
tubes and the plasmid DNA was stored at -20° C.

Microinjections
Xenopus laevis females were injected with 600-800 units of chorionic gonadotropin
12-15 hours before fertilization to stimulate ovulation. Eggs were collected and placed in
0.3X Mark's Modified Ringers (MMR) solution. The male was anaesthetized with 0.5%
(w/v) tricaine 3-aminobenzoic acid in water and the testes were extracted and placed in IX
MMR solution. Half of a testis was homogenized and used to fertilize the eggs. Embryos
were pi petted in 1% (w/v) cysteine solution with a pH between 7.8-8.1 for 5 minutes and
then rinsed with water and placed in O.lX MMR + 5% Ficoll solution. Three batches of 5075 embryos were injected in a 16.5° C temperature-controlled room with water (control),
pCAX + 571, and pCAX +57 1M (control). The first set ofmicroinjections used a plasmid
concentration of 50 pg/nl and the second set of injections had 100 pg/nl. Each embryo was
injected with 10 nl of plasmid, so for the first set of injections, the total DNA dose was 500
pg per embryo, and for the second set of injections the total DNA dose was I ng per embryo.
All microinjections occurred before the first cellular cleavage. Microinjected embryos were

6

stored at room temperature in O.IX MMR + 5% Ficoll solution. Samples of 12-15 embryos
were taken 1 hour, 24 hours, and 48 hours after microinjection and stored at -80° C.

Protein Extraction
Protein extracts were prepared to give a final concentration of 2 embryo equivalents
of protein per 10 !J.l of sample. Embryos were homogenized on ice in homogenization buffer
with a volume of2/3 of the calculated final sample volume, based on the number of embryos
per sample. The homogenization buffer was comprised of 50 mM HEPES, 150mM NaCl, 5
mM EDTA, 5 mM EGTA, 1% NP-40, at a pH of7.5. Samples were extracted with an equal
volume of Freon, then centrifuged in a fixed-angle Eppendorf Centrifuge 5415 C rotor at
14,000 rpm for 15 minutes at 4° C. Supernatants were transferred to fresh tubes, to which 0.5
volume of3X SDS sample buffer (NEB) and 1/29 volume 1.25 MDTT (New England

BioLabs) were added. Samples were boiled at 100°C for 5 minutes and stored at -20° C.

Protein Assay
Protein concentrations were obtained through a BCA protein assay. A master mix of
reagents A and B, from the Pierce BCA Protein Assay Reagent kit, consisted of 98.0%
reagent A and 2.0% reagent B. The samples of homogenized embryonic samples were added
to the aliquots of master mix in a 1:20 concentration. The samples were then read on a Nanodrop using BCA Protein protocol.
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SDS-PolyaClylamide Gel Electrophoresis (SDS-PAGE)

Proteins were electrophoresed through a 10% separating gel composed of 0.38M
1RIS.HC1 pH 8.8, 10% (w/v) acrylamide/bis, 0.1% SDS, 0.05% ammonium persulfate
(APS), and 6.67 M TEMED; and a 4% stacking gel composed of 0.05 M 1RIS.HC1 pH 6.8,
4% (v/v) acrylamide/bis, 0.1% SDS, 0.05% APS, and 2.67 M TEMED. The electrophoresis
was conducted at 200V for 30 minutes in a Bio-Rad Mini Trans-blot electrophoresis unit and
tbe gel was stained for 30 minutes witb Coomassie blue R-250 (0.1% Coomassie blue R-250,
40% methanol, 10% acetic acid). The gel soaked overnight in destain consisting of 10%
methanol and 10% acetic acid. The gel was visualized witb a Coomassie blue protocol on tbe
BioRad ChemiDoc XRS+ gel documentation system running Image Lab Software.

Western Blot

Proteins were electrophoresed on a 12% separating gel composed of0.375 M
1RIS.HC1 pH 8.8, 12% (w/v) acrylamide/bis, 0.1% SDS, 0.05% ammonium persulfate
(APS), and 6.67 M TEMED; and a 4% stacking gel, see Protein Gel. The electrophoresis was
at 200V for 30 minutes and tbe resultant gel soaked in transfer buffer for 30 minutes. The
transfer buffer was at a pH of 8.3 and consisted of25mM TRIS, 192 mM glycine, and 20%
(v/v) methanol. The nitrocellulose was soaked in transfer buffer for 15 minutes prior to transblotting. Trans-blotting was performed at !SOmA for 1 hour at 4° C. After transfer, the
nitrocellulose was incubated overnight in a blocking solution, 5% (w/v) bovine serum
albumin (BSA) in 1RIS buffered saline (20mM TRIS and 500mMNaCl at a pH of7.5) with
0.1% (v/v) Tween 20 (IX TBST). The nitrocellulose was placed in ephrin-A5 primary
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antibody (Novus Biologicals) diluted 1:500 in TBST and left to incubate overnight at 4°C.
The filter was washed on a shaker table with TBST six times for 5 minutes each. It was then
incubated overnight at 4 °C in a 1:2000 dilution of goat anti-rabbit IgG conjugated to
horseradish peroxidase (HRP; sc-2004, Santa Cruz Biotechnology, INC.). Nitrocellulose was
washed on a shaker table in TBST six times for 5 minutes each and then placed in a I: 1
Clarity1M Western ECL Substrate for 5 minutes. Since the ladder was removed during the
TBST washes, alignment marks were made on the nitrocellulose and the nitrocellulose was
imaged prior to antibody probing. Imaging was accomplished with a BioRad ChemiDoc
XRS+ gel documentation system running Image Lab Software and using white light to form
an image of the protein markers. The image could then be measured and used to determine
molecular weights of the proteins on the probed nitrocellulose. Antibody-bound protein
bands were visualized with a chemiluminol imaging system.

Nitrocellulose Antibody Stripping
To remove bound antibodies for reprobing of the nitrocellulose, it was placed in a 0.1
M glycine (pH 2.5) solution for 30 minutes at room temperature. The nitrocellulose was then
ready to proceed with a new Western blot, starting at the blocking solution.

Protein Concentrations by Reprobing
Nitrocellulose was stripped of its original antibodies and reprobed with antibodies
against housekeeping proteins to ensure even loading of the gel. The filter from the first
experiment, with 50 pg/nL ofpCAX+571 and pCAX+571M injected samples, was reprobed
with purified mouse anti-p190 monoclonal antibody (diluted 1:1000) and anti-Mouse IgG
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(H+L) secondary antibody. The second blot, with 100 pg/nL ofpCAX+571 and
pCAX+57 1M injected samples, was rep robed with a 1:1000 dilution of JLA20 anti-actin
primary antibody (Invitrogen) and 1:2000 sc-2064 Goat anti-mouse IgM-HRP secondary
antibody.

Results
In order to assess the quality of protein extracts from the embryonic samples, SDSPAGE was conducted (Figure 1). The figures' labels can be read as the time-sample, thus 1
corresponds to 1 hour after injection, 24 corresponds to 24 hours after injection, and 48
corresponds to 48 hours after injections. The H 2 0 corresponds to the water control injection
sample, the 571 corresponds to the pCAX+571 variable injection sample, and the 571M
corresponds to the pCAX+571M control injection sample. The SDS-PAGE showed the
protein samples were intact and thus in good condition to move forward with the Western
blot. The protein samples did appear to decrease in concentration as the embryos matured,
which can be attributed to episodes of cell death within the sample. Although the embryos
appeared to be in good condition when sampled for protein extractions, as development
progresses it is inevitable there will be cell death, which could lead to sampling dying
embryos.
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Figure 1. SJJS-PA GE ofproteins extracted from embryos injected with 500 pg of either
pCAX+571 or pCAX+571M The lanes,from left to right, are samples taken 1 hour, 24
hours, and 48 hours after injections from the water, pCAX+ 571, and pCAX+ 571M samples.
The gel was visualized with a BioRad ChemiDoc XRS+ gel documentation system running
Image Lab Software, using the Coomassie blue protocol. The gel shows that the protein
samples followed the expected pattern for an in vivo extraction. The proteins decreased in
intensity with time due to cellular death and expanded the range of normal in vivo proteins
This allowed for the conclusion that the method ofprotein extraction was successful and
yielded intact proteins to continue to use. The samples appear to be less concentrated as the
embryos develop, which is most likely due to the embryonic samples containing embryos with
cell death.

A Western blot, using the samples from the embryos injected with 500 pg of plasmid,
was performed to visualize any knockdown of ephrin-AS expression the pCAX+571 plasmid
may have induced. The proteins were detected with an anti-ephrin-AS antibody. Figure 2
shows this Western blot at a two-minute exposure and suggests that no knockdown of ephrinAS expression occmTed. The band that represents ephrin-AS, at 21 kDa, appears stronger in
each of the pCAX+571 samples compared to the controls in the same sample times. The

11

nitrocellulose also includes bands representing proteins larger than ephrin-A5, which were
unidentifiable, but can be assumed to be proteins that cross-reacted with the antibodies used
(Figures 2 and 4).
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Figure 2. Western blot ofproteins extracted from embryos injected with 500 pg of either
pCAX+571 or pCAX+571M The lanes,from left to right, are samples taken I hour, 24
hours, and 48 hours after injections from the water, pCAX+571, and pCAX+571 M samples.
The protein marker was added separately as a picture taken of the nitrocellulose with white
light because the ladder disappeared during the washing process. Antibody-bound protein
bands were visualized using a BioRad ChemiDoc XRS+ gel documentation system running
Image Lab Software, using the chemiluminescence protocol. The bands larger than ephrinA5 can be attributed to proteins with similar epitopes to ephrin-A5 binding to the ephrin-A5
antibody and proteins that may interact solely with the secondary antibody. The
nitrocellulose seems to show that 500 pg ofpCAX+571 was unable to knockdown ephrin-A5
expression.

To determine the relative protein concentrations in each sample, the original Western
blot, shown in Figure 2, was stripped of its antibody and reprobed with anti-p190, which
should be present at all embryonic stages in equal amounts between 185kDa and 21 OkDa.
The newly blotted nitrocellulose (Figure 3) shows that among the samples taken 1 hour after
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injections, the pCAX+571 and pCAX+571M samples have relatively equal amounts of
protein. However, the water-injected sample had significantly less protein. Among the
samples taken 24 hours after injections all three samples seem to have relatively the same
amount of protein. Among the samples taken 48 hours after injections the water and
pCAX+571M samples seem to have relatively the same amount of protein. However, they
both have significantly less protein than the pCAX+571 protein. Unfortunately protein
concentrations were unable to be obtained for these specific samples, and thus we have to
rely on the reprobed nitrocellulose as a means of relative concentrations. However, prior to
performing the next Western blot, and to decrease confusion, a protein assay will be used to
determine protein concentrations in each protein sample. Based on this information, it still
appears that 500 pg of the pCAX+571 was not enough to knock down the expression of
ephrin-A5.
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Figure 3. Western blot repro bed with p190 antibodies from embryos injected with 500 pg of
either pCAX+571 or pCAX+571M The lanes, from left to right, are samples taken 1 hour,
24 hours, and 48 hours after injections from the water, pCAX+5 71, and pCAX+571 M
samples. The protein marker was added separately as a picture taken of the nitrocellulose
with white light because the ladder disappeared during the washing process. Antibody-bound
protein bands were visualized using a BioRad ChemiDoc XRS+ gel documentation system
running Image Lab Software, using the chemiluminescence protocol. The nitrocellulose
confirms the protein concentrations were not equal.

To detern:llne if a higher dose of pCAX+571 was capable of knocking down the
expression ofephrin-A5, a new set of embryos was injected with 1 ng ofeitherpCAX+571
or pCAX+57 1M. A protein assay was performed to determine the protein concentration in
each of the protein samples taken from the emb1yos, which was used for determining how
much sample to load into each well in the Western blot (See Table 1).
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Table 1. Protein assay of embryonic samples injected with 1 ng ofpCAX+ 571, pCAX+ 571M,
or water.
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The volume of each protein sample loaded into the SDS-PAGE for the Western blot
of embryonic samples injected with 1 ng of plasmid can be seen in Table 2.

A second Western blot was performed to determine if the 1 ng dose of plasmid would
knock down the expression of ephrin-A5. As seen in Figure 4, the band representing ephrinAS (21kDA) in each of the pCAX+571 wells does not decrease in intensity over time when
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compared to the controls. This suggests that pCAX+571 is not capable of knocking down
ephrin-A5 in Xenopus laevis.
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Figure 4. Western blot ofproteins extracted from embryos injected with I ng of either
pCAX+57I or pCAX+57IM The lanes, from left to right, are samples taken I hour, 24
hours, and 48 hours after injections from the water, pCAX+ 57 I, and pCAX+ 57 I M samples.
The protein marker was added separately as a picture taken of the nitrocellulose with white
light because the ladder disappeared during the washing process. Antibody-bound protein
bands were visualized using a BioRad ChemiDoc XRS+ gel documentation system utilizing
Image Lab Software and the chemiluminescence protocol. The bands larger than ephrin-A5
can be attributed to proteins with similar epitopes to ephrin-A5 binding to the ephrin-A5
antibody and proteins that may interact solely with the secondary antibody. The persistence
of2I KDa band suggests that I ng ofpCAX+57I was unable to knockdown the expression of
ephrin-A5.

The lane containing water injected embryonic protein samples taken 24 hours after
injections looks significantly less concentrated compared with the other 24 hour samples.
Based on this observation, the nitrocellulose was stripped and reprobed with anti-actin
antibody, viewed at 43kDa, to verity even protein loading in each lane (Figure 5). After
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viewing the newly probed nitrocellulose, it appears that the concentrations of proteins within
each time set are relatively equal, however there is slightly less protein in the water injected
24 hour sample compared to the pCAX+571 and pCAX-571M 24 hour samples. It can still
be assumed that any changes observed in the 1 ng Western blot were not due to a difference
in protein concentrations. This does not change the results of the 1 ng Western blot. The
wells containing proteins expressed in the cells bearing pCAX+571 did not show that the
band at about 21 kDA, representing ephrin-AS, diminished in intensity at any of the time
samples.
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Figure 5. Western blot ofproteins extracted from embryos injected with 1 ng of either
pCAX+571 or pCAX+571Mreprobedwith anti-actin antibodies,. The lanes,from left to
right, are samples taken 1 hour, 24 hours, and 48 hours after injections from the water,
pCAX+571, or pCAX+571 M samples. The protein marker was added separately as a picture
taken of the nitrocellulose with white light because the ladder disappeared during the
washing process. Antibody-bound protein bands were visualized using a BioRad ChemiDoc
XRS+ gel documentation system utilizing Image Lab Software and the chemiluminescence
protocol. The image suggests that the total protein concentrations in each well were nearly
equal relative to each sample set.

To ensure that the band being considered ephrin-A5 on the Western Blots was in-fact
the correct band with a size of 2lkDa, a standard curve was created for the protein marker
used in the SDS-PAGE and subsequently the Western Blot. Based on this curve and the
length the assumed band traveled, it can be concluded that the band does sit at 2lkDa and can
be considered ephrin-A5. The standard curve and the weight of the significant bands on the
Western blot can be seen in Figure 6.
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Figure 6. The relationship between the molecular weight and the distance the protein
migrated in the SDS-PAGE. The three prominent protein bands on the Western blot were
compared to the standard curve of the protein marker used and their sizes were corifirmed.
This graph confirms that the smallest major band is 21 kDa. and can be assumed to be
ephrin-A5.

Discussion
Ephrin-A5's presence at the zygote stage suggests that it plays a significant role in
embryonic development. Using Xenopus laevis as a model organism, shRNA was used in an
attempt to knock down the expression of ephrin-A5 in developing embryos. This method was
used in a previous study that successfully knocked down the expression of ephrin-A5 in
chicken embryos by 40% using a different plasmid, pCAX+236 (Winning and Krull, 2011). I
attempted to use pCAX+571 to knockdown ephrin-A5 expression because the 571 sequence
contains greater sequence identity to the Xenopus sequence than the 236 sequence (which
was designed against the chicken gene). However, the results show that pCAX+571 is
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ineffective in knocking down ephrin-A5 expression in Xenopus laevis embryos. This is
similar with the findings in a previous study, where the pCAX+57! was not effective in
knocking down ephrin-A5 expression in the hind limbs of chicks (Winning and Krull, 2011 ).
Though one cannot assume the same outcome in chickens and frogs, the similarities between

Xenopus laevis and chickens render similar outcomes possible. The results made it
impossible to determine ephrin-A5's function in embryonic development. Nevertheless, it did
confirm that using pCAX+571 is not the best choice to knock down ephrin-A5 expression.
The experimental design, however, has been shown to be sound. Neither the microinjected
water nor pCAX+571M hindered the expression of ephrin-A5 or the development of the

Xenopus laevis embryos.

The Western blot showed interesting bands that were larger than the expected band
representing ephrin-A5. These bands were unidentifiable proteins but may be attributed to
various in vivo proteins cross-reacting with either the primary or secondary antibody. There
may be proteins with similar epitopes to ephrin-A5 that can cross-react with the primary
antibody (anti-ephrin-A5) or proteins that could have cross-reacted with the secondary
antibody. To determine if any of the proteins interacted with the secondary antibody solely
and the expected size of the proteins, another Western blot would need to be performed with
only the secondary antibody used as a probe. Another possible reason is the fact that the antiephrin-A5 antibody used was tested against humans, mice, and rats, not frogs. This could
have an impact because the difference in epitopes between mammals and amphibians may be
great enough to alter the main protein being probed; thus causing different bands to be more
prominent than the bands representing ephrin-A5. According to Novus Biologicals, the anti-
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ephrin-A5 probe has not been used in Xenopus laevis previously, resulting in no comparable
data available for review. According to Novus Biologicals, there is a possibility, however,
that the band present at 29.5 kDa may be a glycosylated form of ephrin-A5, which would
expand the interpretation of results to include this band. Including this new data does not
change the results ofpCAX-571, however. The plasmid still seems to be ineffective in
knocking down ephrin-A5 expression. In regards to the 47.5 kDa band, Novus Biologicals
attributed it to being either an aggregate or multimer of the ephrin-A5 protein. This further
suggests that the full amount of ephrin-A5 cannot be seen at the expected band and may
suggest that the full amount of the protein did not migrate into the separating gel, but that
some may have remained in the stacking gel. If this were the case, then all three prominent
bands would need to be considered to be ephrin-A5 and reinterpreted. However, even when
including all three bands it still cannot be concluded that pCAX-571 was effective against
ephrin-A5 synthesis.

In regards to why pCAX+571 did not knockdown ephrin-A5 expression, there may be
many undetermined reasons. However, it has been shown that when testing shRNA plasmids,
on average one in four will give 2':70% knockdown, one in four will give about a 50%
knockdown, and half will be ineffective at knocking down the protein expression of interest
(Life Technologies, 2006). The pCAX+571 was chosen as one of the possible plasmids to
knock down ephrin-A5 expression in Xenopus laevis. However, the sequence of the shRNA
(starting at position 571) was based on the sequenced Xenopus tropicalis genome,
specifically its ephrin-A5 gene. This is due to the fact that Xenopus laevis 's ephrin-A5 gene
has not been completely sequenced.
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Future research is needed to determine ephrin-AS' s function in developing Xenopus
laevis embryos and to test other plasmids' effectiveness to knock down ephrin-AS. Though
pCAX+571 was not based on Xenopus laevis's sequenced ephrin-AS gene, the genes should
be nearly the same. This is based on the fact that Xenopus laevis and Xenopus tropicalis
genomes are nearly identical (NCBI). The ephrin-AS sequence starting at position 571 is
identical between tropicalis and chickens, thus tropicalis and laevis are most likely identical
as well. For example, based on a random protein expression search in UniGene small nuclear
RNA auxiliary factor 2 in Xenopus tropicalis is 97.4% identical in function to Xenopus laevis
and has a 99% positive base sequence match. Though pCAX+571 was ineffective in
knocking down ephrin-AS expression, it is unlikely that, if utilizing different plasmids based
on Xenopus tropicalis, a knockdown will not occur. This, however, may not be necessary.
Recently the first copy of Xenopus laevis' s genome has been released to the public (JamesZorn et. al2012). Thus, shRNA plasmids may now be able to be based on Xenopus laevis's
genome. With or without this new information, new shRNA plasmids need to be tested.
Three plasmids encoding ephrin-AS shRNA that should be tested start at positions 236, 248,
and 373, which are three plasmids tested in a previous study and shown to be successful
when transfected into developing chicks (Winning and Krull, 2011). Once a plasmid is found
to knock down ephrin-AS, research can begin to determine ephrin-AS's function in
developing embryos and provide increasing knowledge of the processes in which Eph-ephrin
signaling is involved.
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